January 23, 2026 a 01:00 pm
BDX: Fundamental Ratio Analysis - Becton, Dickinson and Company
Becton, Dickinson and Company, a key player in the healthcare sector, holds a diversified portfolio spanning medical supplies, devices, and diagnostic products. The company's stability in providing essential healthcare solutions reflects positively on its stock analysis. Investors should note the fundamental strengths and weaknesses as part of a comprehensive evaluation.
Fundamental Rating
The overall fundamental rating of Becton, Dickinson and Company is solid, with a balance in profitability and valuation metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
Reviewing historical scores shows the consistency and adjustments in BDX's financial health over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-22 | 3 | 5 | 3 | 3 | 1 | 2 | 3 |
| Previous | 0 | 5 | 3 | 3 | 1 | 2 | 3 |
Analyst Price Targets
The current analyst price target for BDX signifies a steady range, pointing to moderate growth expectations.
| High | Low | Median | Consensus |
|---|---|---|---|
| $215 | $210 | $210 | $211.67 |
Analyst Sentiment
Analyst sentiment reflects a cautious optimism with a majority leaning towards 'Hold'.
| Rating | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 17 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Becton, Dickinson and Company showcases stable financial performance with strong fundamentals in cash flow and profitability metrics. However, the low debt-to-equity ratio indicates caution due to leverage factors. With a 'Hold' consensus among analysts, the focus remains on balanced growth strategies. Investors are advised to consider upcoming sector trends which might impact the company's portfolio, especially amid healthcare market shifts. The stock remains a reliable component, but close monitoring is recommended for any strategic investment adjustments.